Condition

Lymphangioleiomyomatosis clinical trials and research

• 7Clinical trials
• 3Countries

Newest Lymphangioleiomyomatosis clinical trials

All recruiting trials (7)

• Long-term safety of Imatinib for patients with Lymphangioleiomyomatosis

  This study is testing if the cancer drug Imatinib is safe and can help women with Lymphangioleiomyomatosis by seeing how it affects their lung health over time.

  Recruiting at 2 sites Phase 1 Columbia University · New York, New York and 1 other locations · NCT06889168

• Registry for pregnant women with Tuberous Sclerosis Complex and Lymphangioleiomyomatosis

  This study is collecting information from pregnant women with Tuberous Sclerosis Complex and Lymphangioleiomyomatosis to see how their health and their babies' health are affected during pregnancy.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT06160310

• Collection of biosamples and clinical data for tuberous sclerosis and lymphangioleiomyomatosis

  This study is collecting blood and tissue samples from people with tuberous sclerosis and lymphangioleiomyomatosis to help researchers learn more about these conditions and how they affect the body over time.

  Recruiting at 25 sites National Tuberous Sclerosis Association · Birmingham, Alabama and 25 other locations · NCT05676099

• Long-term safety and effectiveness of sirolimus for treating LAM

  This study is testing how safe and effective sirolimus is for people with lymphangioleiomyomatosis (LAM) over a long period of time while keeping track of their lung health and any side effects.

  Recruiting at 8 sites University of Cincinnati · Stanford, California and 19 other locations · NCT02432560

• Comparing nebulized and inhaled albuterol for lung function in women with LAM

  This study is testing whether using a nebulizer or an inhaler for albuterol helps women with LAM breathe better.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT01799538

• Registry for lymphangioleiomyomatosis cases in France

  This study is gathering information about people with lymphangioleiomyomatosis in France to better understand how the disease affects them and how it is being treated.

  Recruiting Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires · Lyon · NCT01484236

• Understanding the disease process of lymphangioleiomyomatosis

  This study looks at how lymphangioleiomyomatosis affects the lungs in women and tries to find out what causes the disease to help develop better treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00001465

Related topics

Quick answers

How many Lymphangioleiomyomatosis clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (6 trials), Canada (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →